130 related articles for article (PubMed ID: 6985825)
1. Combination chemotherapy with cyclophosphamide, adriamycin, intermediate dose methotrexate, and folinic acid rescue (CAMF) in advanced lung cancer.
Robert F; Omura G; Bartolucci AA
Cancer; 1980 Jan; 45(1):1-5. PubMed ID: 6985825
[TBL] [Abstract][Full Text] [Related]
2. Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycin.
Creech RH; Catalano RB; Harris DT; Engstrom PF; Grotzinger PJ
Cancer; 1979 Jan; 43(1):51-9. PubMed ID: 367574
[TBL] [Abstract][Full Text] [Related]
3. Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma.
Ribas A; Albanell J; Solé-Calvo LA; Gallardo E; Bellmunt J; Vera R; Vidal R; Carulla J; Baselga J
Cancer; 1998 Mar; 82(5):878-85. PubMed ID: 9486577
[TBL] [Abstract][Full Text] [Related]
4. Prolonged disease-free survival in advanced breast cancer treated with "super-CMF" adriamycin: an alternating regimen employing high-dose methotrexate with citrovorum factor rescue.
Henderson IC; Gelman R; Canellos GP; Frei E
Cancer Treat Rep; 1981; 65 Suppl 1():67-75. PubMed ID: 6976832
[TBL] [Abstract][Full Text] [Related]
5. Four-drug combination chemotherapy in advanced lung cancer: methotrexate, doxorubicin, cyclophosphamide and CCNU.
Milstein D; Robinson E
Cancer; 1981 Dec; 48(11):2358-63. PubMed ID: 7028245
[TBL] [Abstract][Full Text] [Related]
6. [Combination chemotherapy with cyclophosphamide, adriamycin, cisplatin, nimustine, and methotrexate (EACAM) in advanced adenocarcinoma of the lung].
Nakanishi F; Mogi H; Sugiishi M; Sugiura I; Ogasawara T; Kinoshita T; Hoshino A
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3413-8. PubMed ID: 3466573
[TBL] [Abstract][Full Text] [Related]
7. [Adriamycin, cyclophosphamide, vincristine and methotrexate combination chemotherapy of small cell lung cancer].
Saito H; Kawatsu H; Saka H; Yamamoto M; Takagi E; Tsunekawa H; Kawachi H; Nagura E; Sakai S; Nishiwaki K
Gan To Kagaku Ryoho; 1988 Jun; 15(6):1909-13. PubMed ID: 2838000
[TBL] [Abstract][Full Text] [Related]
8. Adriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer: a randomized trial.
Muss HB; White DR; Richards F; Cooper MR; Stuart JJ; Jackson DV; Rhyne L; Spurr CL
Cancer; 1978 Nov; 42(5):2141-8. PubMed ID: 363253
[TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy of advanced sarcomas in adults with "CYOMAD" (S7).
Lynch G; Magill GB; Sordillo P; Golbey RB
Cancer; 1982 Nov; 50(9):1724-7. PubMed ID: 6981452
[TBL] [Abstract][Full Text] [Related]
10. Combination radiotherapy and chemotherapy for small cell carcinoma of the lung.
Goldberg RS; Joss RA; Bedwinek J; Yates JW; Krakoff IH
Med Pediatr Oncol; 1979; 7(3):241-5. PubMed ID: 232239
[TBL] [Abstract][Full Text] [Related]
11. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
12. MACC chemotherapy for adenocarcinoma and epidermoid carcinoma of the lung: low response rate in a Cooperative Group Study. Eastern Cooperative Oncology Group.
Vogl SE; Mehta CR; Cohen MH
Cancer; 1979 Sep; 44(3):864-8. PubMed ID: 476598
[TBL] [Abstract][Full Text] [Related]
13. High-dose, brief duration, multiagent chemotherapy for metastatic breast cancer.
Lamar RE; Greco FA; Johnson DH; Murphy PB; Hainsworth JD
Cancer; 1994 Apr; 73(7):1842-8. PubMed ID: 8137208
[TBL] [Abstract][Full Text] [Related]
14. A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancer.
Subramanyan S; Abeloff MD; Bond SE; Davidson NE; Fetting JH; Gordon GB; Kennedy MJ
Cancer Chemother Pharmacol; 1999; 43(6):497-502. PubMed ID: 10321510
[TBL] [Abstract][Full Text] [Related]
15. [Combination chemotherapy with cyclophosphamide, adriamycin, cisplatin, nimustine(ACNU), and methotrexate (EACAM) in advanced adenocarcinoma of the lung].
Nakanishi F; Sugiishi M; Ogasawara T; Sugiura I; Kinoshita T; Ito Y; Hoshino A
Gan To Kagaku Ryoho; 1985 Jun; 12(6):1339-44. PubMed ID: 3859252
[TBL] [Abstract][Full Text] [Related]
16. Metastatic non-small cell bronchogenic carcinoma: a randomized trial of sequential vs combination chemotherapy.
Hoffman PC; Newman SB; Golomb HM; Demeester TR; Blough RR; Sovik CA
Eur J Cancer Clin Oncol; 1983 Jan; 19(1):33-8. PubMed ID: 6303793
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate as a single agent and in combination chemotherapy for the treatment of non-Hodgkin's lymphoma of unfavorable histology.
Canellos GP; Skarin AT; Rosenthal DS; Moloney WC; Frei E
Cancer Treat Rep; 1981; 65 Suppl 1():125-9. PubMed ID: 6173118
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy with methotrexate, adriamycin, cyclophosphamide and CCNU (MACC) for nonsmall cell lung cancer. 4-year experience with 92 patients.
Buccheri G; Ferrigno D; Vola F; Curcio A
Oncology; 1989; 46(4):212-6. PubMed ID: 2544837
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy of metastatic breast cancer: a randomized trial comparing the use of adriamycin to that of Vinblastine.
Bezwoda WR; de Moor NG; Derman D; Lange M; Saner R; Dando R
Cancer; 1979 Aug; 44(2):392-7. PubMed ID: 383254
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy with mitomycin C, adriamycin, and cyclophosphamide in advanced adenocarcinoma and large cell carcinoma of the lung.
Fraile RJ; Samson MK; Baker LH; Talley RW
Cancer Treat Rep; 1979; 63(11-12):1983-7. PubMed ID: 230896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
